Article
2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition.
Molecular cancer therapeutics - 1 Jul 2007
Schwartz Pamela S, Manion Michael K, Emerson Christine B, Fry John S, Schulz Craig M, Sweet Ian R, Hockenbery David M
Abstract excerpt
Overexpression of Bcl-x(L) in multiple cancers correlates with resistance to chemotherapy and radiation therapy, and provides a rationale for development of small-molecule Bcl-x(L) inhibitors. Based on knockout studies, nonneoplastic cells also require Bcl-x(L) survival functions, particularly wh...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
